THURSDAY, June 22, 2023 (HealthDay News) — Screening newborns for severe combined immunodeficiency — SCID, sometimes referred to as “bubble boy disease” — significantly increases survival rates, researchers say. Infants with SCID appear healthy at birth, but have no immune defenses, making them highly susceptible to severe and often fatalContinue Reading

FRIDAY, May 19, 2023 (HealthDay News) — A new brain bank is accepting future donations from living athletes, in an effort to perform long-term research into the effects of sports-related concussion. The National Sports Brain Bank (NSBB) at the University of Pittsburgh will track the health of living participants onContinue Reading

FRIDAY, May 19, 2023 (HealthDay News) — Scientists say they’ve identified 10 pesticides that kill neurons involved in Parkinson’s disease, marking a leap forward in their understanding of the movement disorder. Pesticide exposure has long been associated with Parkinson’s, but investigators hadn’t been able to pinpoint specific culprits. A teamContinue Reading

WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading